Investment Snapshot
Weights: Health 30% · Earnings Quality 25% · Momentum 20% · Industry Rank 15% · Smart Money 10%. Scores are computed from reported financials and recalculated daily. Not investment advice.
Share Price and Basic Stock Data
Last Updated: March 24, 2026, 4:57 am
| PEG Ratio | 0.09 |
|---|
Competitors
| Stock Name ⇩ | Market Cap ⇩ | Current Price ⇩ | High / Low ⇩ | Stock P/E ⇩ | Book Value ⇩ | Dividend Yield ⇩ | ROCE ⇩ | ROE ⇩ | Face Value ⇩ |
|---|---|---|---|---|---|---|---|---|---|
| Murae Organisor Ltd | 38.8 Cr. | 0.19 | 1.12/0.19 | 2.56 | 1.02 | 0.00 % | 4.20 % | 5.69 % | 1.00 |
| Evoq Remedies Ltd | 6.27 Cr. | 2.52 | 6.11/2.30 | 3.56 | 17.9 | 0.00 % | 0.35 % | 0.26 % | 10.0 |
| Brooks Laboratories Ltd | 131 Cr. | 44.5 | 166/36.3 | 6.07 | 39.3 | 0.00 % | 9.93 % | 12.2 % | 10.0 |
| Par Drugs & Chemicals Ltd | 102 Cr. | 82.6 | 122/78.0 | 7.31 | 86.5 | 0.00 % | 18.4 % | 13.6 % | 10.0 |
| Alpa Laboratories Ltd | 106 Cr. | 50.2 | 120/46.0 | 8.95 | 92.0 | 0.00 % | 15.0 % | 11.5 % | 10.0 |
| Industry Average | 19,815.15 Cr | 1,053.84 | 53.84 | 201.20 | 0.39% | 16.35% | 15.16% | 6.10 |
Quarterly Result
| Metric | Jun 2022 | Sep 2022 | Dec 2022 | Mar 2023 | Jun 2023 | Sep 2023 | Dec 2023 | Mar 2024 | Jun 2024 | Sep 2024 | Dec 2024 | Mar 2025 | Jun 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 4.28 | 7.11 | 1.17 | 1.53 | 1.71 | 0.43 | 0.40 | 0.86 | 0.23 | 58.01 | 281.05 | 515.53 | 3.99 |
| Expenses | 4.76 | 7.05 | 1.04 | 0.32 | 2.37 | 1.38 | 0.34 | -0.44 | 0.47 | 56.88 | 275.79 | 511.64 | 3.05 |
| Operating Profit | -0.48 | 0.06 | 0.13 | 1.21 | -0.66 | -0.95 | 0.06 | 1.30 | -0.24 | 1.13 | 5.26 | 3.89 | 0.94 |
| OPM % | -11.21% | 0.84% | 11.11% | 79.08% | -38.60% | -220.93% | 15.00% | 151.16% | -104.35% | 1.95% | 1.87% | 0.75% | 23.56% |
| Other Income | 0.87 | 0.00 | 1.40 | 0.00 | 0.66 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 9.00 |
| Interest | 0.00 | 0.00 | 0.14 | 0.15 | 0.26 | 0.01 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Depreciation | 0.02 | 0.02 | 0.03 | 0.03 | 0.02 | 0.02 | 0.02 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| Profit before tax | 0.37 | 0.04 | 1.36 | 1.03 | -0.28 | -0.98 | 0.04 | 1.30 | -0.24 | 1.13 | 5.26 | 3.89 | 9.94 |
| Tax % | 0.00% | 0.00% | 0.00% | 74.76% | 0.00% | -11.22% | 0.00% | 10.00% | 0.00% | 19.47% | 23.76% | 26.74% | 25.15% |
| Net Profit | 0.36 | 0.04 | 1.37 | 0.26 | -0.28 | -0.87 | 0.04 | 1.17 | -0.24 | 0.90 | 4.01 | 2.85 | 7.44 |
| EPS in Rs | 0.00 | 0.00 | 0.02 | 0.00 | -0.00 | -0.01 | 0.00 | 0.02 | -0.00 | 0.00 | 0.02 | 0.01 | 0.04 |
Last Updated: December 27, 2025, 4:37 am
Profit & Loss - Annual Report
Last Updated: October 15, 2025, 3:27 am
| Metric | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 | TTM |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Sales | 0 | 9 | 19 | 23 | 35 | 51 | 55 | 41 | 21 | 14 | 3 | 855 | 859 |
| Expenses | 0 | 9 | 18 | 23 | 34 | 47 | 54 | 49 | 25 | 13 | 4 | 845 | 847 |
| Operating Profit | 0 | 0 | 1 | 0 | 2 | 3 | 1 | -8 | -4 | 1 | -0 | 10 | 11 |
| OPM % | 2% | 3% | 2% | 4% | 7% | 2% | -19% | -21% | 7% | -15% | 1% | 1% | |
| Other Income | 0 | 0 | 0 | 0 | 0 | 0 | 2 | 9 | 8 | 2 | 1 | 0 | 9 |
| Interest | 0 | 0 | 0 | 1 | 1 | 1 | 1 | 1 | 0 | 0 | 0 | 0 | 0 |
| Depreciation | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Profit before tax | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 0 | 3 | 3 | 0 | 10 | 20 |
| Tax % | 31% | 44% | 33% | 27% | 27% | 26% | 25% | 28% | 29% | 29% | 25% | ||
| Net Profit | 0 | 0 | 0 | 0 | 1 | 2 | 2 | 0 | 2 | 2 | 0 | 8 | 15 |
| EPS in Rs | 0.07 | 0.11 | 0.23 | 0.42 | 0.02 | 0.00 | 0.02 | 0.02 | 0.00 | 0.04 | 0.07 | ||
| Dividend Payout % | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% | 0% |
Growth
Last Updated: September 5, 2025, 3:21 pm
Balance Sheet
Last Updated: December 10, 2025, 4:13 am
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Equity Capital | 0.01 | 0.01 | 0.11 | 0.11 | 0.31 | 0.31 | 6 | 6 | 12 | 12 | 49 | 186 |
| Reserves | 0 | 1 | 1 | 1 | 5 | 6 | 8 | 8 | 4 | 6 | 6 | 23 |
| Borrowings | 0 | 1 | 2 | 2 | 7 | 10 | 9 | 11 | 9 | 9 | 0 | 213 |
| Other Liabilities | 0 | 3 | 6 | 7 | 7 | 8 | 12 | 2 | 3 | 1 | 64 | 231 |
| Total Liabilities | 0 | 5 | 9 | 11 | 20 | 23 | 36 | 28 | 29 | 29 | 120 | 652 |
| Fixed Assets | 0 | 0 | 0 | 0 | 0 | 0 | 1 | 1 | 1 | 0 | 0 | 0 |
| CWIP | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Investments | 0 | 0 | 0 | 0 | 0 | 0 | 3 | 0 | 0 | 0 | 0 | 0 |
| Other Assets | 0 | 5 | 9 | 11 | 19 | 23 | 32 | 27 | 28 | 28 | 120 | 652 |
| Total Assets | 0 | 5 | 9 | 11 | 20 | 23 | 36 | 28 | 29 | 29 | 120 | 652 |
Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
Free Cash Flow
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Free Cash Flow | 0.00 | -1.00 | -1.00 | -2.00 | -5.00 | -7.00 | -8.00 | -19.00 | -13.00 | -8.00 | 0.00 | -203.00 |
Free Cash Flow = Income Generated from Operational Activities - Borrowings - Capital Work in Progress (CWIP)
Consistent positive free cash flow is crucial for businesses as it indicates their ability to generate cash from their core operations. It provides financial flexibility, allowing companies to invest in growth opportunities, pay dividends to shareholders, reduce debt, and weather economic downturns more effectively.
Financial Efficiency Indicators
| Month | Mar 2014 | Mar 2015 | Mar 2016 | Mar 2017 | Mar 2018 | Mar 2019 | Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Mar 2025 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Debtor Days | 125 | 87 | 56 | 111 | 78 | 112 | 95 | 261 | 217 | 1,225 | 108 | |
| Inventory Days | 71 | 78 | 108 | 91 | 86 | 97 | 122 | 179 | 392 | 1,439 | 1 | |
| Days Payable | 113 | 107 | 83 | 77 | 54 | 83 | 10 | 18 | -25 | 7 | 85 | |
| Cash Conversion Cycle | 82 | 58 | 82 | 125 | 111 | 126 | 207 | 422 | 635 | 2,657 | 24 | |
| Working Capital Days | 81 | 24 | 34 | 64 | 57 | 79 | 143 | 279 | 472 | 5,034 | 160 | |
| ROCE % | 0% | 22% | 21% | 22% | 25% | 24% | 17% | 4% | 12% | 12% | 1% | 4% |
This stock is not held by any mutual fund.
Key Financial Ratios
| Month | Mar 20 | Mar 19 |
|---|---|---|
| FaceValue | 10.00 | 10.00 |
| Basic EPS (Rs.) | 2.95 | 53.84 |
| Diluted EPS (Rs.) | 2.95 | 53.83 |
| Cash EPS (Rs.) | 3.11 | 55.06 |
| Book Value[Excl.RevalReserv]/Share (Rs.) | 23.51 | 192.64 |
| Book Value[Incl.RevalReserv]/Share (Rs.) | 23.51 | 192.64 |
| Revenue From Operations / Share (Rs.) | 89.35 | 1642.90 |
| PBDIT / Share (Rs.) | 5.70 | 108.68 |
| PBIT / Share (Rs.) | 5.54 | 107.46 |
| PBT / Share (Rs.) | 3.97 | 73.78 |
| Net Profit / Share (Rs.) | 2.94 | 53.84 |
| NP After MI And SOA / Share (Rs.) | 2.95 | 53.84 |
| PBDIT Margin (%) | 6.37 | 6.61 |
| PBIT Margin (%) | 6.19 | 6.54 |
| PBT Margin (%) | 4.44 | 4.49 |
| Net Profit Margin (%) | 3.29 | 3.27 |
| NP After MI And SOA Margin (%) | 3.30 | 3.27 |
| Return on Networth / Equity (%) | 12.55 | 27.94 |
| Return on Capital Employeed (%) | 21.50 | 38.80 |
| Return On Assets (%) | 4.65 | 7.14 |
| Long Term Debt / Equity (X) | 0.09 | 0.43 |
| Total Debt / Equity (X) | 0.60 | 1.40 |
| Current Ratio (X) | 1.58 | 1.55 |
| Quick Ratio (X) | 0.96 | 0.80 |
| Interest Coverage Ratio (X) | 3.63 | 3.23 |
| Interest Coverage Ratio (Post Tax) (X) | 2.88 | 2.60 |
| Enterprise Value (Cr.) | 37.89 | 0.00 |
| EV / Net Operating Revenue (X) | 0.68 | 0.00 |
| EV / EBITDA (X) | 10.78 | 0.00 |
| MarketCap / Net Operating Revenue (X) | 0.53 | 0.00 |
| Price / BV (X) | 2.02 | 0.00 |
| Price / Net Operating Revenue (X) | 0.53 | 0.00 |
| EarningsYield | 0.06 | 0.00 |
About the Company - Qualitative Analysis
| INDUSTRY | ADDRESS | CONTACT |
|---|---|---|
| Pharmaceuticals | Block-B, Office No.702, Dev Auram, Anandnagar Char Rasta, Ahmedabad Gujarat 380015 | Contact not found |
| Management | |
|---|---|
| Name | Position Held |
| Mr. Chinmay Shrikant Pradhan | Managing Director |
| Mr. Nitinkumar Ashokkumar Tomar | Non Executive Director |
| Mr. Krunalbhai Desai | Non Executive Director |
| Mr. Ankit Patel | Independent Director |
| Mr. Mayur Sureshkumar Vyas | Independent Director |
| Ms. Vaishaliben Patel | Independent Director |
FAQ
What is the intrinsic value of Murae Organisor Ltd and is it undervalued?
As of 15 April 2026, Murae Organisor Ltd's intrinsic value is ₹1.64, which is 763.16% higher than the current market price of ₹0.19, suggesting the stock is undervalued. This is calculated using the PE ratio method factoring in ROE (5.69 %), book value (₹1.02), dividend yield (0.00 %), and 5-year EPS CAGR.
What is the current share price and 52-week range of Murae Organisor Ltd?
Murae Organisor Ltd is trading at ₹0.19 as of 15 April 2026, with a FY2026-2027 high of ₹1.12 and low of ₹0.19. The stock is currently near its 52-week low. Market cap stands at ₹38.8 Cr..
How does Murae Organisor Ltd's P/E ratio compare to its industry?
Murae Organisor Ltd has a P/E ratio of 2.56, which is below the industry average of 53.84. Trading at a steep discount to peers could signal a value opportunity or reflect concerns about the company's fundamentals.
Is Murae Organisor Ltd financially healthy?
Key indicators for Murae Organisor Ltd: ROCE of 4.20 % is on the lower side compared to the industry average of 16.35%; ROE of 5.69 % is below ideal levels (industry average: 15.16%). Dividend yield is 0.00 %.
Is Murae Organisor Ltd profitable and how is the profit trend?
Murae Organisor Ltd reported a net profit of ₹8 Cr in Mar 2025 on revenue of ₹855 Cr. Compared to ₹2 Cr in Mar 2022, the net profit shows an improving trend.
Does Murae Organisor Ltd pay dividends?
Murae Organisor Ltd has a dividend yield of 0.00 % at the current price of ₹0.19. The company is currently not paying meaningful dividends.

